Quoin Pharmaceuticals, Ltd. ( QNRX) - Stock Earnings
QNRX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
QNRX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -4.3 million USD | — USD |
| 2026Q1 | -5.0 million USD | — USD |
| 2026Q2 | -5.5 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
QNRX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -8.7 million USD | — USD |
| 2024 | -9.0 million USD | — USD |
| 2025 | -15.8 million USD | — USD |
| 2026 Est. | — | — |
QNRX
Price: $3.99
52 week price:
Earnings Per Share: -5.50 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 102500
Market Capitalization: 9.1 million